Operating income increased 41.9%
Operating income changed +41.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +41.9% from the comparable as-filed period.
Operating margin changed +2428831 basis points from the comparable as-filed period.
Research & development changed +58.3% from the comparable as-filed period.
Cash & equivalents changed -55.3% from the comparable as-filed period.
Capex / revenue changed -4874 basis points from the comparable as-filed period.
Current liabilities changed +424.3% from the comparable as-filed period.
Stock-based compensation changed +181.0% from the comparable as-filed period.
Total assets changed +36.5% from the comparable as-filed period.
SBC / revenue changed -149868 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.